COVID-19 Chest Manifestation on CT Scan and Associated Risk Factors for Developing Pulmonary Fibrosis

被引:0
作者
Bakhsh, Noha [1 ]
Banjar, Mai [2 ]
机构
[1] King Abdulaziz Univ, Fac Med Rabigh, Dept Med, Div Radiol, Jeddah, Saudi Arabia
[2] King Abdullah Med Complex, Dept Med Imaging, Jeddah, Saudi Arabia
关键词
comorbidities; pulmonary fibrosis; risk factor; computed tomography (ct); covid-19; FEATURES;
D O I
10.7759/cureus.56616
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: This retrospective study describes the imaging findings on chest computed tomography (CT) scans of coronavirus disease 2019 (COVID-19) patients as well as the prevalence of pulmonary fibrosis and the potential risk factors for the disease. Methods: One of the major COVID-19 centers in the western province of Saudi Arabia, the King Abdullah Medical Complex in Jeddah, was the site of this study. All adult COVID-19 patients who got a CT chest scan between January 2020 and April 2022 were included in the trial. The imaging findings and pulmonary severity scores (PSS) were obtained from the patients' CT chest. Patients were divided into two groups according to the evidence of fibrotic -like lung changes; clinical and radiological data between the two groups were subsequently compared. Data from the patients' electronic records was collected. esults: The average patient age was 56.4 years, and most (73.5%) patients were men. Two-thirds of the patients had comorbidities (69.1%). CT scans revealed that diffuse lung infiltration is reported in 61% of cases, followed by lower lobes in 19.9%. Ground glass opacity (94.1%), consolidation (76.5%), septal thickening, and/or reticulation (24.4%) were the main chest findings during the initial CT scan. Fibrotic -like lung changes were developed in 9.6% of patients. Patients known to have a positive history of hypertension (p -value = 0.031) and coronary artery disease (CAD) (p -value = 0.011) were found to be significantly more likely to develop lung fibrosis. The patients' pneumonia severity score was significantly higher among the lung fibrotic patients (p -value = 0.026). Also, patients who were diagnosed with pulmonary fibrosis stayed longer in the hospital (p -value 0.001). Sex and age did not correlate significantly with risk of lung fibrosis. Conclusion: Pulmonary fibrosis was observed in 9.6% of COVID-19 patients. A close follow-up of patients with severe pneumonia, prolonged hospitalization, and pre-existing CAD and hypertension was necessary, as pulmonary fibrosis was more likely to occur as a result of these factors. There is a need for a thorough, long-term investigation with a large sample size.
引用
收藏
页数:10
相关论文
共 30 条
  • [1] Post COVID-19 pulmonary complications; a single center experience
    Ahmed, Okba F.
    Kakamad, Fahmi H.
    Amin, Bnar J. Hama
    Abdullah, Berwn A.
    Hassan, Marwan N.
    Salih, Rawezh Q.
    Mohammed, Shvan H.
    Othman, Snur
    Ahmed, Gasha S.
    Salih, Abdulwahid M.
    [J]. ANNALS OF MEDICINE AND SURGERY, 2021, 72
  • [2] Post-COVID-19 pneumonia lung fibrosis: a worrisome sequelae in surviving patients
    Ali, Rasha Mostafa Mohamed
    Ghonimy, Mai Bahgat Ibrahim
    [J]. EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2021, 52 (01)
  • [3] Post COVID-19 pulmonary fibrosis; a meta-analysis study
    Amin, Bnar J. Hama
    Kakamad, Fahmi H.
    Ahmed, Gasha S.
    Ahmed, Shaho F.
    Abdulla, Berwn A.
    Mohammed, Shvan H.
    Mikael, Tomas M.
    Salih, Rawezh Q.
    Ali, Razhan K.
    Salh, Abdulwahid M.
    Hussein, Dahat A.
    [J]. ANNALS OF MEDICINE AND SURGERY, 2022, 77
  • [4] [Anonymous], 2020, Interim Guidelines for Collecting, Handling, and Testing ClinicalSpecimens for COVID-19
  • [5] Complications after discharge with COVID-19 infection and risk factors associated with development of post-COVID pulmonary fibrosis
    Aul, Raminder
    Gates, Jessica
    Draper, Adrian
    Dunleavy, Anne
    Ruickbie, Sachelle
    Meredith, Helen
    Walters, Nicola
    van Zeller, Cristiano
    Taylor, Victoria
    Bridgett, Michael
    Dunwoody, Roisin
    Grubnic, Sisa
    Jacob, Tersesa
    Ong, Yee Ean
    [J]. RESPIRATORY MEDICINE, 2021, 188
  • [6] Performance of Radiologists in Differentiating COVID-19 from Non-COVID-19 Viral Pneumonia at Chest CT
    Bai, Harrison X.
    Hsieh, Ben
    Xiong, Zeng
    Halsey, Kasey
    Choi, Ji Whae
    Tran, Thi My Linh
    Pan, Ian
    Shi, Lin-Bo
    Wang, Dong-Cui
    Mei, Ji
    Jiang, Xiao-Long
    Zeng, Qiu-Hua
    Egglin, Thomas K.
    Hu, Ping-Feng
    Agarwal, Saurabh
    Xie, Fang-Fang
    Li, Sha
    Healey, Terrance
    Atalay, Michael K.
    Liao, Wei-Hua
    [J]. RADIOLOGY, 2020, 296 (02) : E46 - E54
  • [7] Large vessel thrombosis in patient with COVID-19, a case series
    Baram, Aram
    Kakamad, Fahmi H.
    Abdullah, Hadi M.
    Mohammed-Saeed, Dana H.
    Hussein, Dahat A.
    Mohammed, Shvan H.
    Abdulrahman, Binar B.
    Mirza, Aram J.
    Abdulla, Berwn A.
    Rahim, Hawbash M.
    Rashid, Mohammed J.
    Mohammed-Al, Farhad F.
    Othman, Yad N.
    Salih, Abdulwahid M.
    [J]. ANNALS OF MEDICINE AND SURGERY, 2020, 60 : 526 - 530
  • [8] Persistent Symptoms in Patients After Acute COVID-19
    Carfi, Angelo
    Bernabei, Roberto
    Landi, Francesco
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (06): : 603 - 605
  • [9] Chest CT Features of COVID-19 in Rome, Italy
    Caruso, Damiano
    Zerunian, Marta
    Polici, Michela
    Pucciarelli, Francesco
    Polidori, Tiziano
    Rucci, Carlotta
    Guido, Gisella
    Bracci, Benedetta
    De Dominicis, Chiara
    Laghi, Andrea
    [J]. RADIOLOGY, 2020, 296 (02) : E79 - E85
  • [10] Chung MS, 2020, EUR RADIOL, V30, P2182, DOI [10.1007/s00330-019-06574-1, 10.1148/radiol.2020200230]